Working… Menu
Trial record 1 of 14 for:    CC-122
Previous Study | Return to List | Next Study

Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03834623
Recruitment Status : Recruiting
First Posted : February 8, 2019
Last Update Posted : August 1, 2019
Bristol-Myers Squibb
Celgene Corporation
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 14, 2023
Estimated Study Completion Date : May 14, 2023